October is Cybersecurity Awareness Month, but for Glooko, the only diabetes management company with multiple industry-leading security certifications, our commitment to protecting patient health data is a year-round mission.

According to Glooko CEO Mike Alvarez, one of our diabetes management company’s core differentiators is our commitment to patient safety and data privacy, which enables us to build and maintain trust with hospitals, health systems, clinics, and people living with diabetes.

As the healthcare industry faces rising cyberattacks, Glooko understands that securing health data and ensuring the security and privacy of this sensitive information is not just a policy — it’s a core responsibility.

Building a Foundation of Trust Through Security Certifications

Security isn’t a single feature you can switch on; it’s a comprehensive framework built on continuous commitment, sophisticated technology, and rigorous auditing.

As the most secure diabetes management platform, Glooko has invested heavily in achieving and maintaining a number of rigorous global security certifications and standards, which serve as a powerful testament to the maturity and diligence of our security practices that safeguard the sensitive personal and health data of our users with diabetes.

Here are the key standards and certifications that build Glooko’s security backbone:

• ISO 27001: This globally recognized information security management standard outlines requirements for an information security management system (ISMS). Achieving this certification means an organization has a systematic approach to managing sensitive company and customer information.
• SOC 2 Type II and SOC 3 Certification: These internationally recognized global reporting standards, validated by an auditing firm, verify that Glooko’s controls across its employees, systems, and processes fully secure all customer data, software, and company assets.
• HITRUST Risk-based, 2-year (r2) Certification: Achieving this healthcare industry gold standard confirms our stringent, independently-audited security controls meet the highest requirements of frameworks like HIPAA and NIST. This places us in an elite group dedicated to protecting sensitive patient health data. Explore our recent study on strengthening our cyber resilience…
• HIPAA Compliance: This U.S. federal law ensures the protection of sensitive patient health information from being disclosed without the patient’s consent or knowledge.
• The NHS Digital Data Security and Protection Toolkit (DSPT): For operations in the U.K., this framework ensures that patient data is handled securely and in a way that respects privacy.
• GDPR: This comprehensive European Union law gives individuals control over their personal data by setting strict rules for how organizations worldwide must collect, process, and protect that information.

How Diabetes Patient Health Data is Protected on a Day-to-Day Basis

Beyond the certifications, hundreds of controls are implemented to ensure data remains secure at Glooko. Our approach, covering protection, defense, response, and recovery, includes:

• Continuous Vulnerability Management: Regular penetration testing and vulnerability scans are conducted to proactively identify and address potential weaknesses in their systems.
• Internal Governance: A dedicated governance board oversees our diabetes management company’s policies, ensuring that security and privacy are considered in all decisions.
• Employee Training: A core element of any security strategy is the people. Team Glooko receives regular, mandatory training on data security and privacy protocols.
• Privileged Access Management: Policies are in place to ensure that only authorized personnel have access to sensitive information.
• Secure Software Development Lifestyle (SSDLC): Security code reviews, threat modeling, and static and dynamic code scans are completed during the software development lifecycle

Your Data, Your Control

A crucial part of data privacy is the user’s right to control their information. We make it clear that personally identifiable data is never shared without explicit consent. When using the platform through a healthcare provider, Glooko functions as a part of the healthcare provider’s operations, always adhering to the same stringent privacy standards.

Our Constant Commitment to Protecting Patient Safety

Cybersecurity Awareness Month is a great starting point, but data protection requires constant, evolving, and year-round efforts because threats are always changing.

Through a combination of robust technical controls, a culture of security, and adherence to global standards, Glooko’s commitment to trust and privacy is a fundamental part of our connected care company beyond October.

Whether training for a marathon or curious about blood sugar trends when out on a neighborhood walk, tracking and uploading fitness and health data is easy with the Glooko Mobile App for people living with diabetes.

Bringing together exercise, health, and diabetes data from compatible diabetes and health monitoring devices and apps with Glooko enhances diabetes management and allows people with diabetes and their healthcare provider to have greater insight about what adjustments might need to be made in care plans. Having the data available in one place makes it easier for care teams to make more informed decisions about treatment moving forward.

As an added benefit, next time people living with diabetes won’t have to guess when their care team asks how many minutes of exercise they did in a week.

Glooko’s Compatibility with Health Monitoring and Fitness Devices and Apps

Our connected care platform is compatible with leading health monitoring and fitness devices and apps like Apple Health, activity trackers and smartwatches from Fitbit, Strava, Garmin, and blood pressure cuffs and scales from Withings. For select diabetes devices, Glooko can share glucose, CGM, and manually entered insulin data in Glooko with Apple Health. Glooko Mobile App users also have the ability to manually track physical activity by selecting a variety of sports and exercises built into the platform and note the duration, calories burned, and intensity (light, medium, and hard).

When coupling these apps and manual entry of exercise history with the glucose, insulin, and the nutrition tracking capabilities of Glooko, the physical activity data provides care teams the ability to craft more personalized treatment plans and to see how different activities affect levels.

Once this helpful exercise data is imported into Glooko through a sync or manually,it can be found in a variety of our Glooko platforms, including Summary, Graphs, and History, depending on the data. This section provides key information such as step count, number of exercises, and duration of exercise alongside key data points healthcare providers use to make recommendations about insulin and other medication changes. The data displayed will automatically adjust to reflect the selected date range with visualizations changing based on the type of data.

Syncing Lifestyle Management Data with Glooko

Glooko also supports blood pressure and weight data from compatible blood pressure cuffs and scales from Withings. Bluetooth- and cloud-enabled devices automatically sync with Glooko while readings from non-Bluetooth devices must be manually entered in the Glooko Mobile App to be viewed alongside other health data.

Unlock Deeper Insights by Sharing Health Data with Care Teams

To share data from compatible fitness and health monitoring devices and apps with care teams or use it as a reference, simply ensure the ProConnect Code used by the healthcare team is added. To do this, select “Care Teams” from the home screen, then “+ Care Team,” and enter the designated ProConnect Code using all lowercase letters.

From the Glooko Mobile App home screen, select “Sync Device” then “Add New Device,” which will prompt the user to select a category of devices to add. On this screen, select “Fitness and Health Devices” to search for compatible devices or apps to connect.

Once the data is synced, it will be shared with the user’s healthcare provider remotely and at the next appointment alongside blood sugar, insulin, and other diabetes data. The healthcare provider will have the advantage of seeing how exercise may be impacting glucose levels and will be better prepared for conversations about any insulin dosing adjustments that should be considered.

Time to Upload Exercise and Lifestyle Management Data to Glooko

Visit our Support Center for help with syncing fitness and health monitoring devices and apps with Glooko.

*Not all product features are available in all countries.

When healthcare professionals manage a large population of patients with diabetes, they often lack a clear, organized, and comprehensive view of patients’ pertinent health data.

To help address this challenge, we designed the new clinic dashboard in the Glooko diabetes management platform. Available in select countries, the dashboard helps healthcare providers, including primary care providers, endocrinologists, and nurses, at hospitals, health systems, and clinics streamline their diabetes population health management.

Developed for busy healthcare professionals, the new Glooko clinic dashboard is based on TIDE (Timely Interventions for Diabetes Excellence) metrics to help address the challenge of managing a large diabetes patient population. This user-friendly view provides at-a-glance insights into patient population trends and key clinic metrics, making it easier for the entire care team to interpret complex data and guide more efficient decision-making and clinic strategy.

Built on TIDE Metrics for Smarter Diabetes Care

Leveraging evidence-based risk identification logic developed by Stanford researchers to further enhance clinical insights, personalize care, and demonstrate scalable, cost-effective outcomes, the TIDE dashboard, which demonstrated in a 2022 study to reduce screen time for healthcare providers reviewing patient data by 86%, is a powerful tool designed to help clinical teams manage large populations of patients with type 1 diabetes.

The TIDE dashboard uses smart algorithms to analyze and remotely monitor data from continuous glucose monitoring (CGM) devices, helping care teams efficiently and effectively manage their patients’ health. Using essential glucose measures like Time in Range and hypoglycemia, the TIDE model also prioritizes which patients need immediate attention by sorting them by clinical risk, so healthcare providers can focus on those who need it most without sifting through every patient’s data individually.

The TIDE model-based Glooko clinic dashboard offers our professional users a user-friendly way to tackle the challenge of managing a large patient population with three intuitive sections.

Understand Patient Population At-A-Glance

The Population Metrics section of the new Glooko clinic dashboard helps care teams understand the overall health and engagement of their clinic’s patient population in a centralized and concise view. This space displays the total number of patients with diabetes, identifies who is actively monitoring their blood glucose by blood glucose monitors (BGM) or CGM, and shows which patients have completed their Glooko account registration and are actively syncing their health data remotely with our connected care platform.

By centralizing these metrics, this comprehensive section of the dashboard helps healthcare providers shape clinic strategy more efficiently and better understand which patients to contact to activate their Glooko account to make more informed decisions based on synced health data.

Prioritize Care Based on Key CGM Metrics

The CGM Patient Risk Stratification section of the new Glooko clinic dashboard helps healthcare providers prioritize patient care and gives care teams a streamlined view of their patient population, sorted by clinical risk based on key glucose metrics from CGMs. Care teams can easily spot which patients need attention first. The dashboard ranks patients using indicators like Time in Range, Time Below Range, and other key CGM indicators, so healthcare providers can prioritize outreach and interventions based on the most important CGM data, making it easier for them to focus their time on the patients who need it most.

Boost Patient Engagement and Optimize Care

The Engagement Metrics module of the new Glooko clinic dashboard helps healthcare providers spot engagement gaps in their patient population over the past 90 days.

The Patient Account Status section examines the patient population to see if they’ve set-up their Glooko account based on Activated, Invited Pending, Never Invited, and Likely Duplicates. With these key metrics, care teams can quickly see which patients with diabetes haven’t completed the sync to Glooko with their diabetes and health monitoring devices as well as the activation process, allowing for more efficient follow-up and activation.

In the Sync Methods section, care teams can see how patients with diabetes are syncing their data with Glooko. When more health data is synced with Glooko from the cloud, Glooko Mobile App, Transmitter, or Uploader, care teams can make more informed and timely treatment decisions.

Experience Glooko’s New Clinic Dashboard

Ready to see how the intuitive, new Glooko clinic dashboard can optimize diabetes population health management at your clinic, hospital, or health system? Contact our team for a demo.

Today marks an important milestone in our mission to transform diabetes care. I am excited to share that Glooko has acquired Monarch Medical Technologies, creators of the EndoTool® Glucose Management System.

With this acquisition, Glooko is positioned to become the only diabetes management company with the potential to connect the full continuum of care — from home to hospital and back again. By bringing together EndoTool’s proven inpatient insulin dosing technology with Glooko’s leading outpatient platform, we aim to create a future where care is seamless, safer, and more supportive for both people living with diabetes and healthcare providers.

For patients, this means fewer disruptions as they move between settings, reduced risk of dangerous glycemic events, and more confidence that their care is connected. For healthcare providers, it means access to tools that simplify complex insulin management, standardize protocols, and free up time to focus on what matters most, which is caring for people.

This step also sets the foundation for Glooko’s future: using data and AI to help clinicians anticipate risks earlier, personalize care at scale, and improve outcomes under value-based models. By aligning advanced technology with clinical guidelines and EHR workflows, we can help hospitals and health systems deliver higher-quality care while lowering costs.

Our mission has always been clear: to simplify diabetes management, strengthen connections across the care team, and improve lives. This acquisition represents an important stride toward that vision.

Together, we are building a future where diabetes care is more connected, proactive, and patient-centered than ever.

We’re excited to announce the latest updates to Glooko Web 25.2 and Mobile 6.12, which are designed to help healthcare providers and people with diabetes by streamlining workflows, providing a new population management dashboard to triage at-risk patients and review population-level metrics, improving data visualizations, and giving care teams more powerful data from compatible devices to enhance diabetes management.

Introducing the New Clinic Dashboard

In this release, we launched a new clinic dashboard in the U.S. designed to give healthcare professionals at-a-glance insights into population health trends and clinic management metrics. This enhancement makes it easier to interpret complex data and guide decisions and clinic strategy more efficiently across care teams.

Other new clinic dashboard highlights include:

• Population Metrics: This section gives a single, concise, and organized view of the clinic’s total patient population, patients monitoring blood glucose, and those with activated accounts using key engagement and monitoring metrics.
• CGM Patient Risk Stratification: This dashboard, modeled after the Timely Interventions for Diabetes Excellence (TIDE) Dashboard, gives healthcare providers a streamlined view of their patient population, ranked by risk level using key glucose metrics and CGM data only. Care teams can identify risk levels using Time in Range, Time Below Range, and other key CGM indicators to prioritize care.
• Engagement Metrics: This section helps healthcare providers spot engagement gaps within their patient population over the past 90 days and take action to get more patients connected and syncing their devices with Glooko. With more synced health data, care teams can make more informed treatment decisions.

Banner Notification for Missing MRN

Glooko’s connected care platform prioritizes deep EHR integration to bring actionable diabetes data into the systems clinicians already use. To help maintain EHR data integrity and ensure patient matching is seamless, Glooko introduced a clear dismissible banner on the patient dashboard to notify clinicians when a Medical Record Number (MRN) is required but missing.

Tandem Basal Profile Switches

A new icon in DayView and WeekView on the Glooko diabetes management platform identifies when a patient changes their Tandem Personal Profile to give better context for insulin delivery.

GLP-1 Dose Enhancements

GLP-1 doses will now be displayed in the Glooko Web and Mobile software with improved messaging and clinical disclaimers. Healthcare professionals will now receive relevant dose range notifications while also providing precise dose information to support better oversight and patient adherence, while patients will see exact GLP-1 doses up to two decimal places as injected.

Device Type Display in PDFs

Glooko will now display controller device types in the PDF Settings Report, helping clinicians more clearly understand where data originated for users of Omnipod® 5 and other select devices. The report will specifically say on a clear device label the upload method (e.g., Android, iOS, Locked Down Controller) used by the patient.

Updated Insulin Statistics Design

The Glooko Mobile App’s insulin card has been redesigned to enhance clarity and consistency, particularly benefiting users with insulin pump data. This update aims to improve the understanding of insulin averages and minimize confusion between pump and total insulin values by displaying data in one unified insulin card.

More Information on the Latest Glooko Release

For more detailed information about these new features intended to enhance clinical practices and transform diabetes, be sure to check the full release notes on our Glooko Support page.

The NHS’s ambitious “Fit for the Future: 10 Year Health Plan for England” outlines a bold vision for the future of healthcare in the country — one that is digitally advanced, community-focused, and prevention-driven. It’s a plan designed to move healthcare from a reactive, hospital-centric model to a proactive, patient-empowering system utilising cutting-edge technologies. Within this transformative agenda, Glooko’s diabetes management platform stands out as an excellent example of how digital health solutions can directly support these crucial goals.

From Analogue to Digital: Empowering Patients and Streamlining Care

At the heart of the NHS’s plan is a commitment to becoming “digital by default.” This means harnessing technology to make healthcare more accessible, efficient, and patient-friendly.

Imagine a world where your health data, whether from your BGM, CGM, insulin pen, or activity tracker, is all in one place. That’s what Glooko offers through its integrations with more than 200 diabetes and health monitoring devices, including wearables, a future standard in the NHS by 2035. By centralising this vital information, it empowers people living with diabetes to take a more active role in managing their diabetes and saves them time by not having to juggle multiple apps or manually record readings.

For healthcare professionals, Glooko centralises health data from their patients into a single platform, helping create the “single, secure and authoritative account of their data” that the NHS aims for. To help reduce time-wasting administrative tasks, streamline workflows, and allow clinicians to have more efficient appointments focused on providing quality care, Glooko is expanding its capability to sync with electronic health record (EHR) systems across England and the rest of Europe. When all the relevant data is at their fingertips and seamlessly flowing between clinical records and the Glooko platform, everyone on the care team, including diabetologists, diabetes specialist nurses, registered dietitians, and general practitioners, can make more informed clinical decisions using our diabetes technology.

With our commitment to safeguarding confidential personal information and handling patient data properly, our diabetes management platform and our company’s practices meet the NHS’s data security standards outlined in the Data Security and Protection Toolkit. We align with the NHS’s requirements for all organisations with access to their patient data and systems.

From Hospital to Community: Enabling Remote Monitoring and Personalised Care

The NHS plan emphasises shifting care away from hospitals and into local communities and even patients’ homes. Glooko is instrumental in making this a reality for diabetes care with its remote patient monitoring capabilities.

This innovative feature of our diabetes software for healthcare providers means fewer trips to the hospital for routine check-ups and more proactive management of diabetes from the comfort of a patient’s home. This not only improves convenience for people living with diabetes but also helps to alleviate pressure on acute hospital services and supports the development of community-based models like “Neighbourhood Health Centres.”

The Glooko connected care platform offers powerful population health analytics. This allows hospitals to view trends and manage their entire patient population more effectively, aligning with the NHS’s goal of preventing illness and managing long-term conditions on a larger scale. The detailed insights provided by Glooko’s data can also support the creation and monitoring of highly personalised care plans, moving closer to the NHS’s goal of offering personal health budgets and tailored support for complex needs like diabetes.

From Sickness to Prevention: Proactive Management and Improved Outcomes

A core tenet of the NHS’s 10 Year Health Plan is a strong focus on prevention and early intervention.

By providing continuous diabetes and related health data and insights, Glooko helps healthcare providers identify potential issues and risks before they escalate. This allows for proactive intervention, which can significantly reduce the likelihood of diabetes-related complications, improving long-term health for patients.

And Glooko isn’t just about data; it’s about demonstrable results. The diabetes management platform has a track record of improving clinical outcomes, including reduced HbA1c levels. These outcomes directly align with the NHS’s aspirations for better health for the population, reduced demand on acute services, and a more sustainable healthcare system.

A Healthier Future for People with Diabetes

We want the NHS 10 Year Health Plan to deliver real improvements for people with diabetes and their care teams. Glooko is more than a diabetes management tool; we’re a strategic partner committed to helping the NHS deliver better care for all patients regardless of wherever they live and whatever they earn.

By accelerating digital transformation, enabling care at home, and championing proactive diabetes management, Glooko is helping build a more efficient, patient-centered, and digitally advanced healthcare system.

With innovative solutions and preferred vendors like Glooko, the NHS is well-equipped to meet the challenges and opportunities ahead as they usher in the future of healthcare in England.

Glooko is excited to showcase how our connected care platform is transforming diabetes care and simplifying diabetes management at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) in Vienna, Austria, from 15 to 19 September 2025.

At booth C6.07 of the international diabetes conference, Team Glooko will provide partners, industry thought leaders, and healthcare professionals with the opportunity to experience our latest innovations.

• Glooko in Action: We’ll provide live demonstrations of the Glooko Web and Mobile App uniquely designed to address the growing complexities in diabetes care and improve health outcomes of people living with diabetes. With Glooko, healthcare providers can simplify diabetes management, reduce administrative burden, and improve clinical workflows to focus more on delivering care and less on managing data.
• Hedia Diabetes Assistant: Glooko’s recent collaboration with Hedia, a trusted bolus calculator already available in the U.K. and Sweden, enhances precision and efficiency for multiple daily insulin dosing. The new integration offers personalised recommendations and streamlined diabetes management for people living with diabetes while providing healthcare professionals with comprehensive insights through Glooko.
• Industry-Leading Device Compatibility: Through our partnerships, Glooko enables people with diabetes to seamlessly sync and analyze health data from more than 200 diabetes and health monitoring devices. This extensive ecosystem, including CGMs, BGMs, insulin pens and pumps, and health and wellness apps, allows for better collaboration with care teams and improved health outcomes.
• EHR Integrations: Glooko is working to expand its capability to sync with EHR systems across Europe, supporting a smoother flow of data between clinical records and our diabetes software. These integrations are designed to help streamline workflows and reduce administrative tasks, enabling healthcare providers to spend more time focusing on efficient, data-driven patient care.

To meet with one of our experts at EASD 2025, schedule a meeting.

We look forward to seeing you in Vienna!

Managing diabetes care has become increasingly complex for clinics, hospitals, and health systems. With a growing number of people living with diabetes relying on multiple devices — glucose meters, continuous glucose monitors (CGMs), insulin pumps, and wearables — healthcare providers face the challenge of piecing together critical data from siloed systems. This fragmentation not only consumes valuable time, but hinders patient care.

At Glooko, we know device integration is the key to solving these challenges and transforming diabetes management. As a market leader in device compatibility, EHR integration, and interoperability, Glooko increases efficiency of clinical workflows by streamlining administrative tasks, enhances patient engagement, and helps deliver better outcomes.

The Challenges of Fragmented Diabetes Management

For healthcare providers, piecing together data from various devices and platforms and apps can feel like an endless puzzle. Without device integrations, clinics and health systems face:

• Disconnected Data: Patient data is scattered across incompatible platforms and apps, making it difficult to understand a patient’s holistic health.
• Inefficient Workflows: Healthcare providers must spend time manually entering or retrieving data instead of focusing their time and expertise to support their patients in achieving better health.
• Limited Patient Engagement: Patients often struggle to track their progress with so many different tools and apps, becoming overwhelmed and losing hope in their ability to make meaningful change.

These challenges contribute to missed opportunities for timely interventions that drive better health outcomes.

How Glooko’s Compatibility Brings Clarity to Diabetes Care

Glooko simplifies diabetes management by integrating data from more than 200 diabetes and health monitoring devices — including Abbott’s FreeStyle Libre CGMs in the U.S. — into a single, user-friendly platform.

Here’s how Glooko’s device compatibility transforms care:

• Data Integration and Interoperability: Glooko consolidates glucose levels, insulin usage, and lifestyle behaviors such as diet and physical activity, giving healthcare providers a holistic view of patient health. Care teams can easily access patient data from a centralized platform.
• Remote Monitoring Capabilities: Healthcare providers can track patient trends and progress between visits, ensuring timely adjustments to care plans and reducing unnecessary appointments and emergency room visits.

Not all devices are available in every country where Glooko is available. The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.

The Many Benefits of Integration for Clinics, Hospitals, and Health Systems

Our industry-leading device compatibility benefits clinics, hospitals, and health systems by streamlining workflows and improving decision-making through a comprehensive view of patient data. With greater efficiency, care teams can focus more on patient care and expand their reach to serve more individuals in need.

• Streamlined Workflows: Staff spend less time on administrative tasks and more time on what they do best: educating and providing care to their patients.
• Improved Decision-Making: A comprehensive view of patient data allows care teams to create more personalized and effective treatment plans.
• Expanded Clinical Footprint: With more time, clinicians can help more patients in need.

To enable more meaningful data insights, Glooko also seamlessly integrates the health data from their patients’ diabetes and health monitoring devices directly into leading EHR systems, eliminating manual uploads and platform switching and reducing administrative burden.

The Key Benefits of Device Integrations for People Living with Diabetes

Glooko’s device integrations benefit people living with diabetes by simplifying their experience and empowering self-management through centralized data, reducing app overload and supporting informed health decisions.

• Simplified Experience: With integrated data, patients no longer need to juggle multiple apps and passwords, or manually report their glucose levels to their provider.
• Empowered Self-Management: Patients can log meals, exercise, and medications directly in the Glooko app, helping them understand how their choices impact their health.

Proven Results Backed by Global Expertise

Glooko has more than a decade of experience integrating diabetes and health monitoring devices worldwide, supporting millions of people living with diabetes. Glooko’s connected care platform, backed by real-world evidence, delivers the reliability, scalability, and insights clinics, hospitals, and health systems need to stay ahead in diabetes care, setting a new standard.

Simplify Diabetes Care with Glooko

The complexity of diabetes management doesn’t have to hold your clinic, hospital, or health system back. By choosing Glooko, you can eliminate data fragmentation, enhance patient care, and create a more efficient, streamlined experience for healthcare providers and people living with diabetes.

Schedule a personalized demo of our digital health platform today and see how your patients’ health data can be integrated directly into your EHR system.

As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps.

With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other.

Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock.

How Glooko integrates with hybrid closed loop systems

Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes.

The hybrid closed loop systems that currently sync with Glooko include:

• mylife Loop (CamAPS FX and Ypsomed)
• Tandem Control-IQ
• Insulet Omnipod 5
• Dana CamAPS® FX

Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems.

Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries).

Benefits of using hybrid closed loop systems with Glooko

There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including:

• Major changes in treatment that reduce daily burdens and mental stress
• More time with glucose levels in range with less effort
• The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates

There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including:

• An increased monitoring of patients with diabetes who are using closed loop systems
• Strengthening their connection with their patients
• Better management of fluctuations in patients’ glucose levels
• Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses

The future of hybrid closed loop systems

Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life.

As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution.

For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.

At Glooko, we empower certified diabetes care and education specialists (CDCES) by equipping them with the tools needed to help individuals with Type 1, Type 2, gestational diabetes, and prediabetes better manage their condition and reduce the risk of complications.

Our connected care platform offers remote patient monitoring, compatibility with more than 200 diabetes and health monitoring devices, and easy-to-read reports. With EHR integrations to streamline clinical workflows and population health dashboards, CDCES professionals can proactively identify trends, tailor care plans, and help improve health outcomes — making diabetes care and education more efficient, data-driven, and impactful.

If you’re a CDCES planning to attend the Association of Diabetes Care & Education Specialists’ ADCES25 in Phoenix, Team Glooko wants to meet you at booth #1131 to share the latest updates to our innovative diabetes management platform and mobile app and give you the opportunity to see how we’re transforming diabetes care.

Some of the exciting features and happenings that you can expect to see at our booth:

• Ask An Expert: Our booth will host Glooko Senior Director of Clinical Transformation Trisha Martinez, MBA, RN, BSN, an accomplished clinician, who will share best practices for how CDCESs can educate people living with diabetes to use Glooko to better manage their condition. Our resident clinical expert will be on-site to hear feedback, tips, and tricks for using our connected care platform.
  • Friday, August 8: 9:30-10:15 a.m. and 12:15-2:15 p.m.
  • Saturday, August 9: 9-9:45 a.m., 11:45-1 p.m., and 3-4 p.m.
• Glooko Web and Mobile App: We’ll provide live demos of Glooko, our cutting-edge connected care platform designed to simplify diabetes management and make it easier for people with diabetes to input, view, and understand their health data. Mobile app users can also take advantage of the innovative food tracker feature to easily log their food intake and view their food data alongside data from compatible devices, medications, and exercise. Best of all, the synced data can be securely shared with care teams to stay on track between appointments!
• New Clinic Dashboard: This summer, we’ll launch a new clinic dashboard in Glooko that provides a high-level view of a patient population and program performance across key areas. The Population Metrics panel tracks total patients, CGM use, and activation rates — updated every 14 days — to highlight trends and engagement gaps. CGM Risk Stratification uses CGM data to rank patients by clinical risk, helping prioritize care. Engagement Metrics show where patients are in their onboarding journey and how they sync data, enabling staff to focus outreach and improve engagement efforts.
• EHR Integrations: Glooko seamlessly integrates with leading EHR systems to securely consolidate diabetes data in one place, removing the need to switch platforms or manage multiple logins. This feature allows healthcare providers to work more efficiently within a single interface that offers a comprehensive view of each patient’s health data.
• Latest Device Compatibility: Glooko now integrates with Abbott’s FreeStyle Libre CGMs in the U.S., offering real-time glucose and lifestyle data in one platform, empowering people with diabetes to take better control of their health, and enabling healthcare providers to make more informed, data-driven decisions.

To meet with one of our experts at ADCES25, schedule a meeting.

See you in Phoenix!

The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.